Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Cadila Healthcare

BSE: 532321|NSE: CADILAHC|ISIN: INE010B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 22, 16:00
245.10
4.7 (1.96%)
VOLUME 62,935
LIVE
NSE
Oct 22, 15:57
245.25
4.6 (1.91%)
VOLUME 1,079,784
Announcements on Cadila Health

18th-Oct-2019 18:36Source: BSE

Cadila Healthcare- Board Meeting Intimation for Unaudited Financial Results For The Quarter / Half Ended On September 30, 2019

CADILA HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2019 ,inter alia, to consider and approve Unaudited Financial Results for the qua...

9th-Oct-2019 10:55Source: BSE

Cadila Healthcare- Compliance Certificate For The Half Year Ended On September 30, 2019

Compliance Certificate for the half year ended on September 30, 2019

8th-Oct-2019 13:21Source: BSE

Cadila Healthcare- Shareholding for the Period Ended September 30, 2019

Cadila Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here

8th-Oct-2019 13:11Source: BSE

Cadila Healthcare- Compliance Certificate For The Half Year Ended On September 30, 2019

Compliance Certificate for the half year ended on September 30, 2019

8th-Oct-2019 09:58Source: BSE

Cadila Healthcare- Statement Of Investor Complaints For The Quarter Ended September 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor compl...

2nd-Oct-2019 09:53Source: BSE

Cadila Healthcare- Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus announces positive results from EVIDENCES IV Phase 2 clinical trial of Saroglitazar Magnesium in NAFLD and NASH

26th-Sep-2019 11:54Source: BSE

Cadila Healthcare- Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus receives final approval from the USFDA for Clobetasol Propionate Lotion.

23rd-Sep-2019 11:42Source: NSE

Cadila Healthcare Limited

Cadila Healthcare Limited has informed the Exchange regarding ''Company??s API manufacturing facility located at Ankleshwar (Unit 1), Gujarat has received an Establishment Inspection Report (EIR). The...

1 2 3 4 5 Next >>
Board Meeting (Cadila Health)

Meeting Date

Remark

2019-11-13

Quarterly Results

Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.